Health Insurance Companies, Marketing and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Health Insurance Companies

Marketing

Pharmaceuticals

Overcoming Healthcare’s Mountain of Mistrust – Part 2: Payers

Perficient: Drug Development

JANUARY 25, 2024

To recap: Part 1 of the series focused on providers This part, Part 2, focuses on payers (insurance companies) Part 3 (by Marlana Voerster ) will focus on medical-device organizations First off: the bad news in trust for payers Gallup’s polling data among U.S. Quite frankly … not much. So there’s not much to celebrate in these results.

Nurses

Nurses Health Insurance Companies Pharmaceutical Companies Hospitals

Combo ‘Polypill’ May Cut Heart Attack, Stroke Risk Up to 40%

The Pharma Data

NOVEMBER 16, 2020

A single pill also is cheaper to market and distribute. Yang pointed out that “the fact that it’s generic is a double-edged sword, because no big pharma company is willing to invest a lot of money in developing and marketing a polypill. If it’s more convenient together, why not?” ” Yusuf said.

Health Insurance Companies

Health Insurance Companies Doctors Medical Schools Pharma Companies

Drug Discovery Digest

Overcoming Healthcare’s Mountain of Mistrust – Part 2: Payers

Combo ‘Polypill’ May Cut Heart Attack, Stroke Risk Up to 40%

Stay Connected